Live Breaking News & Updates on Senhwa Biosciences Inc

Stay updated with breaking news from Senhwa biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

《TAIPEI TIMES》 GBC seeks US authorization for oral COVID-19 drug - 焦點

By Kao Shih-ching / Staff reporterGolden Biotechnology Corp （GBC, 國鼎） plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said. ....

T Ai Pei , Liu Sheng Yung , Chen Yung Chi , Alan Tseng , Senhwa Biosciences Inc , Labcorp Drug Development , Taipei Exchange On , Taipei Exchange , Golden Biotechnology Corp , Taipei Times , Kao Shih Ching , Biotechnology Corp , Emerging Stock Board , Iberty Times Net ,

Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma

/PRNewswire/ Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and. ....

United States , T Ai Pei , San Diego , South Korea , John Soong , Senhwa Biosciences , Senhwa Bioscience , Senhwa Biosciences Inc , Us National Institute Of Health , Drug Administration , Cancer Therapy Evaluation Program , Prnewswire Senhwa Biosciences Inc , Pediatric Brain Tumor Consortium , Orphan Drug Designation , Chief Medical Officer , Surgical Study , Therapy Evaluation Program , Fast Track Designation , Rare Pediatric Disease , Priority Review Voucher , Rare Pediatric Disease Designation , Sonic Hedgehog ,

Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma

/PRNewswire/ Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and. ....

United States , T Ai Pei , San Diego , South Korea , John Soong , Senhwa Biosciences , Senhwa Bioscience , Senhwa Biosciences Inc , Us National Institute Of Health , Drug Administration , Cancer Therapy Evaluation Program , Prnewswire Senhwa Biosciences Inc , Pediatric Brain Tumor Consortium , Orphan Drug Designation , Chief Medical Officer , Surgical Study , Therapy Evaluation Program , Fast Track Designation , Rare Pediatric Disease , Priority Review Voucher , Rare Pediatric Disease Designation , Sonic Hedgehog ,

Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United States , T Ai Pei , San Diego , South Korea , Senhwa Biosciences , Senhwa Bioscience , Senhwa Biosciences Inc , American Academy Of Dermatology , Prnewswire Senhwa Biosciences Inc , Poster Presentation Center , Basal Cell Carcinoma , Exhibit Hall , American Academy , Orphan Drug Designation , Rare Pediatric Disease Designation , Fast Track Designation , Sonic Hedgehog , Coronavirus Pandemic , Pr Newswire ,

Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting

/PRNewswire/ Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and. ....

United States , T Ai Pei , San Diego , South Korea , Senhwa Biosciences , Senhwa Bioscience , Senhwa Biosciences Inc , American Academy Of Dermatology , Poster Presentation Center , Basal Cell Carcinoma , American Academy , Orphan Drug Designation , Rare Pediatric Disease Designation , Fast Track Designation , Sonic Hedgehog ,